The Asbestos Files

They Knew. They Said Nothing.

From 1934 to the 1970s, asbestos manufacturers received repeated, documented warnings that their products caused fatal lung disease. This is the timeline of their response.

By Staff Reporter, AsbestosAccountability.org Investigation ongoing since 2026 4,200+ documents reviewed

Central Finding

Internal documents obtained through asbestos litigation proceedings reveal that major manufacturers were warned about the lethal dangers of asbestos as early as 1934 — more than 40 years before meaningful regulatory action was taken. Rather than informing workers, these companies suppressed research, discredited independent scientists, and lobbied against health and safety regulations.

1930s: The First Warnings

1918

US and Canadian insurance companies stop selling life insurance to asbestos workers

Aetna Life and other major insurers quietly stop underwriting life insurance policies for asbestos workers, citing the "injurious conditions of the industry" in internal actuarial reports. Asbestos manufacturers are informed. No warnings are issued to workers.

1930

Metropolitan Life Insurance study confirms asbestosis — results suppressed

Metropolitan Life Insurance Company completes a study of asbestos workers at Johns-Manville's Manville, New Jersey plant. The study confirms that asbestosis — a fatal scarring of the lung tissue — is prevalent among long-term asbestos workers. Johns-Manville negotiates control over the study's publication. Key findings are omitted. Workers are not informed.

📄 Internal memo, Johns-Manville Corporation, 1934: "It is the company's policy that where men get asbestosis they are not told until the disease has progressed to the point that they are disabled."
1934

Aetna Life warns manufacturers: asbestos workers face significantly elevated mortality

Aetna Life Insurance issues a formal warning to asbestos manufacturers documenting elevated mortality rates among asbestos workers, describing conditions in asbestos manufacturing as an "occupational hazard." The warning is received and acknowledged. No change in worker notification policy occurs.

1935

Johns-Manville and Raybestos-Manhattan agree to suppress research publication

In a documented agreement, executives at Johns-Manville Corporation and Raybestos-Manhattan agree that the results of an independent medical study documenting lung disease in asbestos workers should not be published. The agreement is memorialized in internal correspondence that would later be obtained through litigation discovery.

📄 Internal memorandum, Sumner Simpson (Raybestos-Manhattan President) to Vandiver Brown (Johns-Manville Attorney), 1935: The original document is held at the Rutgers University Asbestos Litigation Archive.

1940s–1950s: Wartime Exposure and Continued Suppression

1941

Navy shipbuilding drives mass asbestos exposure among US servicemen

World War II naval expansion creates the largest single asbestos exposure event in American history. US Navy vessels are insulated with asbestos throughout — in engine rooms, pipe insulation, boiler rooms, and living quarters. Hundreds of thousands of servicemen and shipyard workers are exposed. Asbestos manufacturers supply the Navy under lucrative contracts.

1949

Johns-Manville's medical director advises not testing workers for asbestosis

Internal correspondence documents Johns-Manville's medical director advising that workers should not be given chest X-rays or informed of early asbestosis findings, because "it would create a liability situation" for the company. Workers with documented lung damage continue working in asbestos environments without notification.

📄 Internal Memorandum — Johns-Manville Corporation 1949 · Attorney-Client Communication · Obtained through litigation discovery
TO: [Corporate Legal] FROM: [Medical Department] RE: Worker chest X-ray program Following review of our current X-ray screening program, we recommend discontinuing the practice of informing employees of early radiological findings. The medical department's position is that notification of subclinical findings creates unnecessary anxiety among workers and — more critically — creates a documentary record that could be used against the company in future claims proceedings. Workers with findings consistent with early asbestosis should be transferred to lower-exposure positions where operationally feasible, without notification of the reason for transfer. This policy has been reviewed by [Legal] and is consistent with our approach in other jurisdictions.
Source: Johns-Manville Corporation internal records, obtained through discovery in Borel v. Fibreboard Paper Products (1973) and subsequent litigation proceedings. Archive: Rutgers University Asbestos Litigation Archive, Document Reference JM-49-MED-021.

1960s: Cancer Evidence Confirmed — and Buried

1964

Dr. Irving Selikoff publishes landmark asbestos-cancer study — industry attacks him

Dr. Irving Selikoff of Mount Sinai Hospital publishes research demonstrating a clear causal link between asbestos exposure and mesothelioma — a previously rare cancer. The study, presented at a New York Academy of Sciences symposium, establishes that asbestos causes cancer in addition to the already-documented asbestosis. Industry-funded researchers immediately attack the methodology.

1966

Industry-funded Saranac Lake laboratory suppresses cancer findings

The Saranac Lake Laboratory, substantially funded by asbestos manufacturers, completes animal studies that confirm asbestos causes cancer in laboratory animals. Internal documents show that manufacturers are briefed on the results. The results are not published. The laboratory receives continued industry funding.

1969

Johns-Manville begins coordinated legal strategy to limit liability exposure

Internal documents show that Johns-Manville's legal department develops a coordinated strategy to contest worker compensation claims, delay litigation, and exploit statutes of limitations. The strategy includes settling early cases quietly to avoid creating legal precedents, and funding independent research designed to cast doubt on the asbestos-cancer link.

📄 Strategy memorandum, Johns-Manville legal department, 1969: "The company's position should be that the causal relationship between our products and the conditions described in claimants' medical reports has not been scientifically established to a degree sufficient to impose liability."

1970s: Regulation Arrives — Too Late for Millions

1971

OSHA establishes first asbestos workplace standard — industry lobbies against it

The newly formed Occupational Safety and Health Administration establishes the first federal asbestos exposure standard. Internal documents show that asbestos manufacturers coordinated lobbying against a stricter standard, providing funding to researchers whose published work cast doubt on the safe exposure threshold. The standard adopted is widely considered inadequate by independent scientists.

1973

Borel v. Fibreboard: First successful asbestos liability verdict — internal documents enter public record

The Fifth Circuit Court of Appeals upholds the first successful asbestos products liability verdict in Borel v. Fibreboard Paper Products. The case results in the entry into the public record of internal corporate documents demonstrating manufacturer knowledge of asbestos dangers. The litigation floodgates open. Tens of thousands of cases are filed.

1982

Johns-Manville files for bankruptcy — the first of 60+ asbestos manufacturer bankruptcies

Faced with more than 16,500 asbestos lawsuits and hundreds of millions in projected liability, Johns-Manville Corporation — America's largest asbestos producer — files for Chapter 11 bankruptcy protection. The bankruptcy establishes a precedent: the creation of a trust fund to compensate current and future victims. More than 60 other asbestos manufacturers will follow.

Context

The companies that filed for bankruptcy did not do so because they were financially ruined by asbestos claims — many were profitable subsidiaries of larger conglomerates. Bankruptcy was a legal strategy to cap liability at a defined amount and continue operating as ongoing businesses under new names or under parent company control.

The result: trust funds that contain only a fraction of the estimated total cost of asbestos-related illness in the United States, which independent economists have estimated at over $200 billion in total economic damages.

Where We Are Today

Asbestos remains legal in the United States. More than 40 countries — including all other developed nations — have enacted comprehensive bans. In the US, every legislative effort to ban asbestos has been defeated, most recently by industry lobbying against the Frank R. Lautenberg Chemical Safety for the 21st Century Act's implementation.

Approximately 3,000 Americans are diagnosed with mesothelioma every year — a number that has remained essentially constant for decades, reflecting the 20–50 year latency period between asbestos exposure and the development of disease. Most patients being diagnosed today were exposed to asbestos in the 1960s and 1970s, before meaningful regulation took effect.

The companies responsible for the exposure that causes these diagnoses established bankruptcy trust funds to compensate victims. As of 2025, these trusts collectively hold approximately $32.7 billion in assets — available to patients and families who can document exposure to the company's products.